Dietary fat intake and prevention of cardiovascular disease: systematic reviewBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7289.757 (Published 31 March 2001) Cite this as: BMJ 2001;322:757
- Lee Hooper, research associate in evidence based care and systematic review ()a,
- Carolyn D Summerbell, reader in human nutritionb,
- Julian P T Higgins, statisticianc,
- Rachel L Thompson, senior research fellow in public health nutritiond,
- Nigel E Capps, consultant chemical pathologist for Shropshiree,
- George Davey Smith, professor of clinical epidemiologyf,
- Rudolph A Riemersma, senior lecturer in cardiac biochemistryg,
- Shah Ebrahim, professor in epidemiology of ageingf
- a Manchester Dental and Education Centre (MANDEC), University Dental Hospital of Manchester, Manchester M15 6FH
- b School of Health, University of Teesside, Middlesbrough, Cleveland TS1 3BA
- c Systematic Reviews Training Unit, Institute of Child Health, London WC1N 1EH
- d Public Health Nutrition, Institute of Human Nutrition, Level B, South Academic Block, Southampton General Hospital, Southampton SO16 6YD
- e Department of Clinical Biochemistry, Princess Royal Hospital NHS Trust, Apley Castle, Telford TF6 6TF
- f Department of Social Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PR
- g Cardiovascular Research, University of Edinburgh, Edinburgh EH8 9XF
- Correspondence to: L Hooper
- Accepted 16 January 2001
Objective: To assess the effect of reduction or modification of dietary fat intake on total and cardiovascular mortality and cardiovascular morbidity.
Design: Systematic review.
Data sources: Cochrane Library, Medline, Embase, CAB abstracts, SIGLE, CVRCT registry, and biographies were searched; trials known to experts were included.
Included studies: Randomised controlled trials stating intention to reduce or modify fat or cholesterol intake in healthy adult participants over at least six months. Inclusion decisions, validity, and data extraction were duplicated. Meta-analysis (random effects methodology), meta-regression, and funnel plots were performed.
Results: 27 studies (30 902 person years of observation) were included. Alteration of dietary fat intake had small effects on total mortality (rate ratio 0.98; 95% confidence interval 0.86 to 1.12). Cardiovascular mortality was reduced by 9% (0.91; 0.77 to 1.07) and cardiovascular events by 16% (0.84; 0.72 to 0.99), which was attenuated (0.86; 0.72 to 1.03) in a sensitivity analysis that excluded a trial using oily fish. Trials with at least two years' follow up provided stronger evidence of protection from cardiovascular events (0.76; 0.65 to 0.90).
Conclusions: There is a small but potentially important reduction in cardiovascular risk with reduction or modification of dietary fat intake, seen particularly in trials of longer duration.
What is already known on this topic
What is already known on this topic The epidemiological relation between dietary fat intake and cardiovascular disease is central in strategies aimed at risk reduction in populations and individuals
Systematic review of randomised controlled trials supports manipulation of dietary fat to control serum lipid concentrations, though evidence of effect on one risk factor does not rule out an opposite or reinforced effect on another unstudied risk factor
Randomised controlled trials of dietary fat reduction or modification have shown varying results on cardiovascular morbidity and mortality
What this study adds
What this study adds Systematic review of trials of modified fat intake shows that reduction or modification of dietary fat intake results in reductions in cardiovascular events, but only in trials of at least two years' duration
There is little effect on total mortality
Despite decades of effort and many thousands of people randomised, there is still only limited and inconclusive evidence of the effects of modification of total, saturated, monounsaturated, or polyunsaturated fats on cardiovascular morbidity and mortality
Funding LH's work on this review was partly funded by a studentship from the Systematic Reviews Training Unit, Institute of Child Health, University of London, and Shropshire Health Authority, Shrewsbury, contributed to travel expenses. RAR is supported by the British Heart Foundation.
Competing interests None declared.
A table giving details of included studies is available on the BMJ's website
- Accepted 16 January 2001